Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

0 of 9 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 3

1(20.0%)

Phase 1

1(20.0%)

5Total

N/A(3)

Phase 3(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT05134116Completed

SafeBoosC III Two-year Follow-up

Role: lead

NCT03983694Completed

Cerebral Haemodynamic Changes by Red Blood Cell Transfusion in Neonates

Role: lead

NCT02815618Completed

An Optical Neuro-monitor of Cerebral Oxygen Metabolism and Blood Flow for Neonatology

Role: lead

NCT03770741Not ApplicableCompleted

Safeguarding the Brain of Our Smallest Infants Phase III

Role: lead

NCT02830503Not ApplicableCompleted

Feeding Tube Practices and Colonization of the Preterm Stomach in the First Week of Life

Role: lead

NCT03091907Completed

Long-term Consequences of Necrotizing Enterocolitis in the Newborn Period

Role: lead

NCT01590316Not ApplicableCompleted

SafeBoosC - a Phase II Trial

Role: lead

NCT02570061Phase 3Completed

Recruiting to Clinical Trials on the Telephone

Role: lead

NCT01530360Phase 1Completed

Cerebral Oxygenation to Guide Medical Interventions in Extremely Preterm Infants

Role: lead

All 9 trials loaded